The presentation was part of the 245th National Meeting & Exposition of the American Chemical Society (ACS), the world's largest scientific society. The meeting, with 12,000 presentations on advances in science and other topics, continues here through Thursday.
Walter Rakitsky, Ph.D, explained that microalgae are the original oil producers on earth, and that all of the oil-producing machinery present in higher plants resides within these single-cell organisms. Solazyme's breakthrough biotechnology platform unlocks the power of microalgae, achieving over 80 percent oil within each individual cell at commercial scale while changing the triglyceride oil paradigm by their ability to tailor the oil profiles by carbon chain and saturation.
The ability to produce multiple oils in a matter of days out of one plant location using standard industrial fermentation is a game-changer. Solazyme's patented microalgae strains have become the workhorses of a growing industry focused on producing commercial quantities of microalgal oil for energy and food applications. Rakitsky is with Solazyme, Inc., of South San Francisco, Calif., one of the largest and most successful of those companies, which in 2011 supplied 100 percent microalgal-derived advanced biofuel for the first U.S. passenger jetliner flight powered by advanced biofuel.
In a keynote talk at the ACS meeting, Rakitsky described Solazyme's technology platform that enables the company to produce multiple oils from heart-healthy high-oleic oils for food to oils that are tailored to have specific performance and functionality benefits in industry, such as safer dielectric fluids and oils that are the highest-value cuts of the barrel for advanced fuels. The benefits of these oils far surpass those of other oils that are currently available today.
"For the first time in history, we have unlocked the ability to completely design and tailor oils," he said. "This breakthrough allows us to create oils optimized for everything from high-performance jet and diesel fuel to renewable chemicals to skin-care products and heart-healthy food oils. These oils could replace or enhance the properties of oils derived from the world's three dominant sources: petroleum, plants and animals."
Producing custom-tailored oils starts with optimizing the algae to produce the right kind of oil, and from there, the flexibility of the fermentation platform really comes into play. Solazyme is able to produce all of these oils in one location simply by switching out the strain of microalgae they use, Rakitsky explained. Unlike other algal oil production processes, in which algae grow in open ponds, Solazyme grows microalgae in total darkness in the same kind of fermentation vats used to produce vinegar, medicines and scores of other products. Instead of sunlight, energy for the microalgae's growth comes from low-cost, plant-based sugars. This gives the company a completely consistent, repeatable industrial process to produce tailored oil at scale.
Sugar from traditional sources such as sugarcane and corn has advantages for growing microalgae, especially their abundance and relatively low cost, Rakitsky said. The company's first fit-for-purpose commercial-scale production plant is under construction with their partner Bunge next to a sugarcane mill in Brazil. Initial production capacity will be 110,000 tons of microalgal oil annually, expanding up to 330,700 tons. In addition, the company has a production agreement with ADM in Clinton, Iowa, for 22,000 tons of oil, expandable to 110,000 tons. Ultimately, cellulosic sources of sugars from non-food plants or plant waste materials, like grasses or corn stover, may take over as those technologies reach the right scale and cost structures.
The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 163,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.
To automatically receive news releases from the American Chemical Society, contact email@example.com.Note to journalists: Please report that this research was presented at a meeting of the American Chemical Society.
Harnessing the oil-producing capabilities of microalgae, Solazyme's biotechnology platform utilizes standard industrial fermentation equipment to efficiently scale and accelerate natural oil development cycle time from years to merely a few days. By feeding simple plant sugars to proprietary strains of microalgae in industrial fermentation vessels, Solazyme takes advantage of "indirect photosynthesis", in contrast to the traditional open-pond approaches most often associated with microalgae.Today, Solazyme's biotechnology platform is pioneering the expanded the use of renewable, resources by producing oils that are tailored to meet specific industry demands, impacting end-use applications ranging from fuels to chemicals to foods. These unique oil profiles have performance and functionality benefits that far surpass what's currently available.
Michael Bernstein | EurekAlert!
Water forms 'spine of hydration' around DNA, group finds
26.05.2017 | Cornell University
How herpesviruses win the footrace against the immune system
26.05.2017 | Helmholtz-Zentrum für Infektionsforschung
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
26.05.2017 | Life Sciences
26.05.2017 | Life Sciences
26.05.2017 | Physics and Astronomy